Integrisano motivaciono intervjuisanje i terapija kognitivnog ponašanja za medijatore životnog stila prekomerne težine i gojaznosti kod odraslih koji žive u zajednici: sistematski pregled i meta-analize.
BMC public health
Sažetak istraživanja
Pozadina
Cilj ove studije bio je da se ispita da li integrisano motivaciono intervjuisanje i kognitivno bihejvioralna terapija dovode do promena u životnim medijatorima prekomerne težine i gojaznosti kod odraslih koji žive u zajednici. Metoda šest elektronskih baza podataka je sistematski pretražena do 04. oktobra 2017. Analize su bile ograničene na randomizirana kontrolirana ispitivanja koja su ispitivala učinak integriranog motivacijskog intervjua i terapije kognitivnog ponašanja na medijatore prekomjerne tjelesne težine i gojaznosti (fizička aktivnost, ishrana, sastav tijela) odraslih u zajednici. Meta-analize su sprovedene korišćenjem rezultata promene od početne vrednosti u merama ishoda specifičnim za medijatore životnog stila prekomerne težine i gojaznosti da bi se odredile standardizovane srednje razlike (SMD) i 95% intervala poverenja (95% CI). The Grades of Recommendation, Assessment, Development and Evaluation approach was used to evaluate the quality of the evidence.
Results Ten randomised controlled trials involving 1949 participants were included.
Rezultati su otkrili umjereno kvalitetne dokaze da su integrirano motivaciono intervjuisanje i terapija kognitivnog ponašanja imali značajan učinak u povećanju nivoa fizičke aktivnosti kod odraslih koji žive u zajednici (SMD: 0,18, 95% CI: 0,06 do 0,31, p Diskusija Dodavanje integriranog motivacijskog intervjua i kognitivno-bihevioralne terapije može dovesti do poboljšanja fizičke aktivnosti u zajednici i poboljšanja tjelesne aktivnosti u našoj zajednici. odrasli Dostupni dokazi pokazuju da je moguće integrirati IM sa KBT i da ova kombinovana intervencija ima potencijal za poboljšanje ishoda u vezi sa zdravljem.
Prikaži originalni naslov i sažetak na engleskom
Integrated motivational interviewing and cognitive behaviour therapy for lifestyle mediators of overweight and obesity in community-dwelling adults: a systematic review and meta-analyses.
Background The aim of this study was to investigate whether integrated motivational interviewing and cognitive behaviour therapy leads to changes in lifestyle mediators of overweight and obesity in community-dwelling adults.
Method Six electronic databases were systematically searched up to 04 October, 2017. Analyses were restricted to randomised controlled trials that examined the effect of integrated motivational interviewing and cognitive behaviour therapy on lifestyle mediators of overweight and obesity (physical activity, diet, body composition) in community-dwelling adults. Meta-analyses were conducted using change scores from baseline in outcome measures specific to the lifestyle mediators of overweight and obesity to determine standardized mean differences (SMD) and 95% confidence intervals (95% CI). The Grades of Recommendation, Assessment, Development and Evaluation approach was used to evaluate the quality of the evidence.
Results Ten randomised controlled trials involving 1949 participants were included.
Results revealed moderate quality evidence that integrated motivational interviewing and cognitive behaviour therapy had a significant effect in increasing physical activity levels in community-dwelling adults (SMD: 0.18, 95% CI: 0.06 to 0.31, p Discussion The addition of integrated motivational interviewing and cognitive behaviour therapy to usual care can lead to modest improvements in physical activity and body composition for community-dwelling adults. The available evidence demonstrates that it is feasible to integrate MI with CBT and that this combined intervention has the potential to improve health-related outcomes.
Conclusion This review details recommendations for future research including the adoption of uniform objective outcome measures and well-defined interventions with sufficient follow-up durations and assessments of treatment fidelity.
Izvorni podaci
- DOI
- 10.1186/s12889-018-6062-9
- PMID
- 30290793
- PMCID
- PMC6173936
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom